CGI (NYSE: GIB) (TSX: GIB.A) has recently unveiled a strategic collaboration with Körber to enhance the production processes within the pharmaceutical and life sciences sectors. This partnership aims to integrate CGI's extensive services with Körber's Werum PAS-X Manufacturing Execution System (MES) Suite, with the ultimate goal of improving efficiency, accuracy, and safety in pharmaceutical product manufacturing. The global collaboration seeks to provide clients with enhanced access to real-time data for more informed decision-making and operational excellence.

Tim Hurlebaus, the President of U.S. Commercial & State Government operations and global executive sponsor for CGI's health and life sciences business, emphasized CGI's commitment to transforming data into actionable insights. The collaboration with Körber is seen as a valuable addition to CGI's portfolio, enabling the delivery of innovative services tailored to the specific needs of clients in the pharma and life sciences industries.

Körber's Werum PAS-X MES Suite serves as a digital, real-time process controller, aiming to reduce time-to-market, lower production costs, and adopt a more patient-centric approach. Compliant with Good Manufacturing Practices, this platform provides a comprehensive view of integrated data systems, offering a crucial advantage in an industry where timing and accuracy are paramount.

Jan-Henrik Dieckert, COO Software at Körber Business Area Pharma, highlighted the unique value proposition resulting from the combination of Körber's global presence and CGI's expertise in pharma and life sciences. CGI's proficiency in IT and operational technology (OT) security ensures a seamless implementation of the platform, covering technical integration, data migration, and organizational change management.

Maiken Lykke, Senior Vice-President at CGI Denmark, stressed CGI's role as a trusted advisor to executives in the pharmaceutical and life sciences sectors, assisting in optimizing operations according to industry priorities. The partnership with Körber is specifically designed to address the distinct challenges faced by clients in the pharmaceutical and life sciences industry.

CGI, recognized for providing clinical and IT solutions, has a significant presence in the global biotech and pharmaceutical sector, serving 11 of the top 20 companies. The collaboration with Körber reinforces CGI's dedication to supporting organizations in optimizing processes, launching new therapies, and driving digital transformation across research & development, manufacturing, and commercial functions on a global scale.

 

Source: prnewswire.com

Report Abuse